545 related articles for article (PubMed ID: 31938938)
1. Axillary management for young women with breast cancer varies between patients electing breast-conservation therapy or mastectomy.
Tadros AB; Moo TA; Stempel M; Zabor EC; Khan AJ; Morrow M
Breast Cancer Res Treat; 2020 Feb; 180(1):197-205. PubMed ID: 31938938
[TBL] [Abstract][Full Text] [Related]
2. Age and Receptor Status Do Not Indicate the Need for Axillary Dissection in Patients with Sentinel Lymph Node Metastases.
Mamtani A; Patil S; Van Zee KJ; Cody HS; Pilewskie M; Barrio AV; Heerdt AS; Morrow M
Ann Surg Oncol; 2016 Oct; 23(11):3481-3486. PubMed ID: 27169771
[TBL] [Abstract][Full Text] [Related]
3. Optimizing Axillary Management in Clinical T1-2N0 Mastectomy Patients with Positive Sentinel Lymph Nodes.
Kantor O; Means J; Grossmith S; Dey T; Bellon JR; Mittendorf EA; King TA
Ann Surg Oncol; 2022 Feb; 29(2):972-980. PubMed ID: 34467507
[TBL] [Abstract][Full Text] [Related]
4. Management of the Axilla in T1-2 Breast Cancer Patients with Macrometastatic Sentinel Node Involvement Who Underwent Breast-Conserving Therapy.
Kuru B; Yuruker S; Sullu Y; Gursel B; Ozen N
J Invest Surg; 2019 Jan; 32(1):48-54. PubMed ID: 28945489
[TBL] [Abstract][Full Text] [Related]
5. The Potential Impact of AMAROS on the Management of the Axilla in Patients with Clinical T1-2N0 Breast Cancer Undergoing Primary Total Mastectomy.
Moossdorff M; Nakhlis F; Hu J; Barry WT; Losk K; Haskett C; Smidt ML; King TA
Ann Surg Oncol; 2018 Sep; 25(9):2612-2619. PubMed ID: 29855827
[TBL] [Abstract][Full Text] [Related]
6. Trends of Axillary Treatment in Sentinel Node-Positive Breast Cancer Patients Undergoing Mastectomy.
Verreck EEF; van Steenhoven JEC; Kuijer A; van Maaren MC; Simons JM; Siesling S; van Dalen T
Ann Surg Oncol; 2023 Sep; 30(9):5623-5632. PubMed ID: 37225832
[TBL] [Abstract][Full Text] [Related]
7. Choice of Mastectomy May Increase the Extent of Axillary Surgery in Women with Breast Cancer.
Zaveri S; Romanoff A; Hirt L; Thompson L; Pisapati KV; Weltz C; Schmidt H; Port E
Am Surg; 2022 Nov; 88(11):2686-2694. PubMed ID: 35081002
[TBL] [Abstract][Full Text] [Related]
8. Omission of axillary lymph node dissection for breast cancer patients with three or more positive sentinel lymph nodes.
Prathibha S; White M; Kolbow M; Hui JYC; Brauer D; Ankeny J; Jensen EH; LaRocca CJ; Marmor S; Tuttle TM
Breast Cancer Res Treat; 2024 May; 205(1):127-133. PubMed ID: 38281296
[TBL] [Abstract][Full Text] [Related]
9. Multidisciplinary Management of the Axilla in Patients with cT1-T2 N0 Breast Cancer Undergoing Primary Mastectomy: Results from a Prospective Single-Institution Series.
Grossmith S; Nguyen A; Hu J; Plichta JK; Nakhlis F; Cutone L; Dominici L; Golshan M; Duggan M; Carter K; Rhei E; Barbie T; Calvillo K; Nimbkar S; Bellon J; Wong J; Punglia R; Barry W; King TA
Ann Surg Oncol; 2018 Nov; 25(12):3527-3534. PubMed ID: 29868979
[TBL] [Abstract][Full Text] [Related]
10. Intraoperative Pathology Assessment May Lead to Overtreatment of the Axilla in Clinically Node-Negative Breast Cancer Patients Undergoing Upfront Mastectomy.
Pride RM; Glass CC; Nakhlis F; Laws A; Weiss AC; Bellon JR; Mittendorf EA; King TA; Kantor O
Ann Surg Oncol; 2023 Oct; 30(10):5978-5987. PubMed ID: 37436607
[TBL] [Abstract][Full Text] [Related]
11. Omitting axillary lymph node dissection after positive sentinel lymph node in the post-Z0011 era: Compliance with NCCN and ASCO clinical guidelines and Z0011 criteria in a large prospective cohort.
Costaz H; Boulle D; Bertaut A; Rouffiac M; Beltjens F; Desmoulins I; Peignaux K; Ladoire S; Causeret S; Loustalot C; Padeano MM; Vincent L; Jankowski C; Arnould L; Coutant C
Bull Cancer; 2022 Mar; 109(3):268-279. PubMed ID: 34838310
[TBL] [Abstract][Full Text] [Related]
12. Evolution in practice patterns of axillary management following mastectomy in patients with 1-2 positive sentinel nodes.
Weiss A; Lin H; Babiera GV; Bedrosian I; Shaitelman SF; Shen Y; Kuerer HM; Mittendorf EA; Caudle AS; Hunt KK; Hwang RF
Breast Cancer Res Treat; 2019 Jul; 176(2):435-444. PubMed ID: 31025270
[TBL] [Abstract][Full Text] [Related]
13. Axillary Surgery for Early-Stage, Node-Positive Mastectomy Patients and the Use of Postmastectomy Chest Wall Radiation Therapy.
Gaines S; Suss N; Barrera E; Pesce C; Kuchta K; Winchester DJ; Yao K
Ann Surg Oncol; 2018 Aug; 25(8):2220-2228. PubMed ID: 29626303
[TBL] [Abstract][Full Text] [Related]
14. Patterns of completion axillary dissection for patients with cT1-2N0 breast cancer undergoing total mastectomy with positive sentinel lymph nodes.
Schwieger L; Postlewait LM; Subhedar PD; Geng F; Liu Y; Gillespie T; Arciero CA
J Surg Oncol; 2024 Mar; 129(3):468-480. PubMed ID: 37955191
[TBL] [Abstract][Full Text] [Related]
15. The intraoperative assessment of sentinel nodes - Standards and controversies.
van der Noordaa MEM; Vrancken Peeters MTFD; Rutgers EJT
Breast; 2017 Aug; 34 Suppl 1():S64-S69. PubMed ID: 28673534
[TBL] [Abstract][Full Text] [Related]
16. Outcomes of Post Mastectomy Radiation Therapy in Patients Receiving Axillary Lymph Node Dissection After Positive Sentinel Lymph Node Biopsy.
Stauder MC; Caudle AS; Allen PK; Shaitelman SF; Smith BD; Hoffman KE; Buchholz TA; Chavez-Macgregor M; Hunt KK; Meric-Bernstam F; Woodward WA
Int J Radiat Oncol Biol Phys; 2016 Nov; 96(3):637-44. PubMed ID: 27681760
[TBL] [Abstract][Full Text] [Related]
17. Microscopic Extracapsular Extension in Sentinel Lymph Nodes Does Not Mandate Axillary Dissection in Z0011-Eligible Patients.
Barrio AV; Downs-Canner S; Edelweiss M; Van Zee KJ; Cody HS; Gemignani ML; Pilewskie ML; Plitas G; El-Tamer M; Kirstein L; Capko D; Patil S; Morrow M
Ann Surg Oncol; 2020 May; 27(5):1617-1624. PubMed ID: 31820212
[TBL] [Abstract][Full Text] [Related]
18. Influence of frozen-section analysis of sentinel lymph node and lumpectomy margin status on reoperation rates in patients undergoing breast-conservation therapy.
McLaughlin SA; Ochoa-Frongia LM; Patil SM; Cody HS; Sclafani LM
J Am Coll Surg; 2008 Jan; 206(1):76-82. PubMed ID: 18155571
[TBL] [Abstract][Full Text] [Related]
19. Stage migration in breast cancer: surgical decisions concerning isolated tumour cells and micro-metastases in the sentinel lymph node.
de Widt-Levert L; Tjan-Heijnen V; Bult P; Ruers T; Wobbes T
Eur J Surg Oncol; 2003 Apr; 29(3):216-20. PubMed ID: 12657229
[TBL] [Abstract][Full Text] [Related]
20. Locoregional Management of the Axilla in Mastectomy Patients with One or Two Positive Sentinel Nodes: The Role of Intraoperative Pathology.
Davis J; Boughey JC; Hoskin TL; Day CN; Cheville JC; Piltin MA; Hieken TJ
Clin Breast Cancer; 2021 Oct; 21(5):458-465. PubMed ID: 33839043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]